Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
20.03.26
/
50%
€28.40
Target price
20.03.27
€51.88
Performance (%)
-6.06%
Price
27.05.26
€27.04
Summary
This prediction is currently active. With a performance of -6.06%, the BUY prediction for Stoke Therapeutics Inc by Canaccord_Genuity_Gr is down slightly. This prediction currently runs until 20.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 8.507% | 8.507% |
| iShares Core DAX® | 1.173% | 4.370% |
| iShares Nasdaq 100 | 2.744% | 12.449% |
| iShares Nikkei 225® | 4.948% | 11.538% |
| iShares S&P 500 | 1.395% | 6.628% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.85
28.04.23
28.04.23
€21.78
28.04.24
28.04.24
28.81%
29.04.24
29.04.24
